EC Number   |
General Information |
Reference |
|---|
   3.2.1.49 | evolution |
occurrence of alpha-N-acetylgalactosaminidases among the marine epiphytic bacteria isolated from green, red, and brown algae, bacteria of the genera Arenibacter, Cellulophaga, Formosa, Maribacter, Zobellia, and Winogradskyella are the prevailing taxa, screening, overview |
-, 732464 |
| 3.2.1.49 | evolution |
the enzyme belongs to the glycoside hydrolase family GH 109 |
732454 |
| 3.2.1.49 | malfunction |
deficiency of alpha-NAGAL activity results in the lysosomal storage disorders Schindler disease and Kanzaki disease, molecular basis, overview |
709530 |
| 3.2.1.49 | malfunction |
enzyme deficiency in Fabry disease causes globotriaosylceramide accumulation in the liver, kidneys, and heart of Fabry patients, phenotype, overview. Wild-type enzyme intravenously injected into Fabry model mice prevents the globotriaosylceramide storage and improves the pathological changes in the organs, overview |
707033 |
| 3.2.1.49 | malfunction |
Schindler disease is a lysosomal storage disorder caused due to deficiency or defective activity of alpha-N-acetylgalactosaminidase |
750879 |
| 3.2.1.49 | more |
comparison of the binding ability of alpha-N-acetylgalactosaminidase with red blood cells in different reaction buffers, such as normal saline, phosphate-buffered saline, a disodium hydrogen phosphate-based buffer, and 5% commercial glucose solution. Glucose buffer is suitable for blood group conversion with alpha-N acetylgalactosaminidase |
731531 |
